Back to RARE
Palo Alto Investors LP RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
6
Latest value
$10.7M
Q3 2026
Peak value
$19.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $10.6M |
| Q1 2026 | $12.5M |
| Q2 2026 | $19.9M |
| Q2 2026 | $19.9M |
| Q2 2026 | $19.9M |
| Q3 2026 | $10.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.7M | 710.0K | — | — |
| Q2 2026 | $19.9M | 596.5K | — | — |
| Q2 2026 | $19.9M | 596.5K | — | — |
| Q2 2026 | $19.9M | 596.5K | — | — |
| Q1 2026 | $12.5M | 596.5K | — | — |
| Q4 2025 | $10.6M | 461.3K | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$260.3M
$219.1M
$213.3M
$205.6M